(MedPage Today) — Vanda Pharmaceuticals said its investigational neurokinin-1 receptor antagonist tradipitant reduced nausea and vomiting from semaglutide (Ozempic, Wegovy) in a randomized trial of people with obesity or overweight.
A KFF poll…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/118581
Author :
Publish date : 2025-11-18 19:01:00
Copyright for syndicated content belongs to the linked Source.
